We have chosen to focus on targeted cancer therapies with increased efficacy and decreased toxicity through the definition of novel drug targets using innovative screening platforms coupled to preclinical models. This effort will build upon strengths in functional screening, cell and tissues models and medicinal chemistry.
NODE LEADERS
Dr Christopher Paige
Dr. Paige is Vice President Research of the University Health Network in Toronto. A Senior Scientist in the Division of Stem Cell and Developmental Biology at the Ontario Cancer Institute, his research interests are centred on the processes involved in development and disregulation of B cells involved in the immune system.
Dr Robert Rottapel
Dr Rottapel is Head of the Division of Stem Cells and Developmental Biology, Ontario Cancer Institute, Toronto. His research interests are centred upon the identification of the molecular pathways involved in blood and lymph node development and carcinogenesis.
